H.R. 1476 · 119th Congress (2025–2027)
PLASMA Act
This bill phases-in certain price adjustments for plasma-derived products under the Medicare prescription drug benefit's Manufacturer Discount Program.
Current law requires manufacturers of covered drugs under the Medicare prescription drug benefit to provide a 10% discount for covered drugs during the initial coverage phase (i.e., before a beneficiary reaches the out-of-pocket spending threshold) and a 20% discount during the catastrophic coverage phase (i.e., after a beneficiary reaches the out-of-pocket spending threshold).
The bill phases-in discounts for plasma-derived products over several years, starting with a 1% discount in 2026 for both the initial and catastrophic coverage phases, and ending with a 10% discount beginning in 2030 for the initial coverage phase and a 20% discount beginning in 2032 for the catastrophic coverage phase.
Show official title
To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 1476’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Richard Hudson (R-NC-9)
- Cosponsors
5 cosponsors
3 original · 2 later
- Rep. Donald G. Davis (D-NC-1)· Original · Feb 21, 2025
- Rep. Gregory F. Murphy (R-NC-3)· Original · Feb 21, 2025
- Rep. Scott H. Peters (D-CA-50)· Original · Feb 21, 2025
- Rep. David Rouzer (R-NC-7)· Later · May 5, 2025
- Rep. Brad Knott (R-NC-13)· Later · Jun 3, 2025
- Policy area
- Health
- Subjects
- Blood and blood diseases
- Drug therapy
- Health care costs and insurance
- Manufacturing
- Medicare
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
PLASMA Act
Display title, Short title · Introduced in House
Preserving Life-saving Access to Specialty Medicines in America Act
Short title · Introduced in House
To amend title XVIII of the Social Security Act to provide a phase-in for plasma-derived products under the manufacturer discount program.
Official title · Introduced in House